News Archives - PharmaNL

Opening PharmaNL SDI subsidy call on March 18, 2025

March 18, 2025

ZonMw, the subsidy administrator of PharmaNL, opens a subsidy call within the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025. The objective of this subsidy call is to address the prioritized themes from PharmaNL’s investment agenda. View this investment agenda, published on January 30, 2025, here. Read the full news article about the […]

Save the Date: PharmaNL Connection Days in March and April 2025

February 13, 2025

PharmaNL is organizing the second edition of the PharmaNL Connection Days! These inspiring networking events, taking place on March 25, April 2, and April 8, offer a unique opportunity to explore collaborations and gain valuable insights into the upcoming funding call within PharmaNL’s Shared Development Infrastructure (SDI) program line. ZonMw, the implementing organization of PharmaNL’s […]

Pre-announcement PharmaNL Shared Development Infrastructure 2025

February 11, 2025

Great news! ZonMw, the managing organization of the PharmaNL subsidy program, is planning to launch a subsidy call for the PharmaNL Shared Development Infrastructure program on Tuesday, March 18, 2025! This subsidy supports the construction and upgrading of advanced infrastructure for pharmaceutical startups, scale-ups, and academic research groups. It’s a unique opportunity to collaborate and […]

PharmaNL publishes Investment Agenda for Shared Development Infrastructure

January 30, 2025

PharmaNL today publishes the Investment Agenda for the Shared Development Infrastructure program line. This document (part 3) is an integral part of the PharmaNL investment agenda as presented on August 22, 2024, focusing on the Human Capital Growth program line. The Investment Agenda serves as a roadmap for investments aimed at strengthening the Dutch pharmaceutical […]

Wanted: Companies for Pilots in Early Drug Discovery Training

December 18, 2024

Is your company struggling to find well-trained personnel for roles within early drug discovery? Radboud University, HAN University of Applied Sciences, and Elevate, who are running the PharmaNL project Early Drug Discovery Education Track, invite companies to collaborate and participate. This project, part of PharmaNL’s Human Capital Growth program, focuses on developing innovative training programs […]

Submitting a Project Idea for PharmaNL’s Human Capital Growth Program? Here’s What You Need to Know!

December 10, 2024

The deadline to submit project ideas is approaching quickly: Monday, January 13, 2025, at 2:00 PM. “This is a firm deadline,” emphasizes Claudia Leusink, Program Manager for PharmaNL at ZonMw. “Without a submitted project idea, you cannot proceed to submit a full grant application. So, start early!”

From Innovation to Transformation: Meet Floor van de Watering, the New Program Manager of PharmaNL

November 11, 2024

Since October 1, Floor van de Watering has taken on the role of program manager at PharmaNL. With over fifteen years of experience in guiding healthcare innovations to market, her career began as a researcher at Radboudumc, where she worked on injectable bone treatments during her PhD and focused on breast tumor detection in her […]

ZonMw opens the funding call on November 5 as part of the PharmaNL Human Capital Growth program.

November 5, 2024

ZonMw opened a funding call on November 5 as part of the PharmaNL Human Capital Growth program. This call aims to address the prioritized themes in PharmaNL’s investment agenda, providing a sustainable boost to the human capital available to the Dutch pharmaceutical industry.

Nanoworx: A New Step in Nanomedicine

October 25, 2024

How can we better harness the potential of nanomedicine? The new initiative Nanoworx, a Contract Research Organisation (CRO), has been established to automate and accelerate the production of innovative nanomedicines. Thanks to a recent grant from PharmaNL in the Shared Development Infrastructure program line, Nanoworx can produce nanomedicine libraries and identify formulations with the best […]

The “PharmaNL Shared Development Infrastructure” project has officially started its funding round.

October 8, 2024

The project “Advancing the Cure: Efficient Screening to Optimize Early-Stage Drug Discovery (ACESO)” will soon commence under the leadership of Judith Rasmussen-Dietvorst, as part of the PharmaNL Shared Development Infrastructure program. This program focuses on creating infrastructure for pharmaceutical products and technologies to advance drug development.